Ultragenyx Pharmaceutical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RARE and other ETFs, options, and stocks.About RARE
Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza.
CEOEmil D. Kakkis
CEOEmil D. Kakkis
Employees1,294
Employees1,294
HeadquartersNovato, California
HeadquartersNovato, California
Founded2010
Founded2010
Employees1,294
Employees1,294
RARE Key Statistics
Market cap2.17B
Market cap2.17B
Price-Earnings ratio-3.91
Price-Earnings ratio-3.91
Dividend yield—
Dividend yield—
Average volume5.63M
Average volume5.63M
High today$23.90
High today$23.90
Low today$22.50
Low today$22.50
Open price$23.45
Open price$23.45
Volume2.76M
Volume2.76M
52 Week high$46.50
52 Week high$46.50
52 Week low$18.41
52 Week low$18.41
Stock Snapshot
With a market cap of 2.17B, Ultragenyx Pharmaceutical(RARE) trades at $23.20. The stock has a price-to-earnings ratio of -3.91.
On 2026-01-09, Ultragenyx Pharmaceutical(RARE) stock traded between a low of $22.50 and a high of $23.90. Shares are currently priced at $23.20, which is +3.1% above the low and -2.9% below the high.
Ultragenyx Pharmaceutical(RARE) shares are trading with a volume of 2.76M, against a daily average of 5.63M.
During the past year, Ultragenyx Pharmaceutical(RARE) stock moved between $18.41 at its lowest and $46.50 at its peak.
During the past year, Ultragenyx Pharmaceutical(RARE) stock moved between $18.41 at its lowest and $46.50 at its peak.
Analyst ratings
95%
of 22 ratingsBuy
95.5%
Hold
4.5%
Sell
0%
People also own
Based on the portfolios of people who own RARE. This list is generated using Robinhood data, and it’s not a recommendation.